Medical Device Development: Benchmarking US Early-Stage Product Management and Promotion
|出版商||Cutting Edge Information||商品編碼||332703|
|出版日期||內容資訊||英文 120 Pages
|醫療設備的開發:美國的早期產品管理、推銷的基準 Medical Device Development: Benchmarking US Early-Stage Product Management and Promotion|
|出版日期: 2015年05月29日||內容資訊: 英文 120 Pages||
As medical device manufacturers navigate an increasingly competitive commercial market, they must ensure they are adequately prepared with the financial and human resources necessary for product success. It is imperative that these companies get an early start on commercialization - some as early as concept and prototype development.
Medical Device Development serves as a guide to medical device organizations that are undertaking new product planning and early commercialization initiatives for US-based launches. The report presents early commercialization profiles for 11 medical devices. Profiles span all company sizes, product classifications product type and novelty, as well as a range of therapeutic areas and focuses. This study also highlights key strategies for maximizing product success, including selecting best-fit regulatory pathways, determining the appropriate laboratory and clinical trials to support submissions, identifying the viability of partnering deals to promote product success, and gathering health economics and market data to build device value.
Medical Device Development showcases benchmarks, best practices, and case studies to improve device product resource allocation, product development planning and early commercialization strategies for US-based launches. Data are broken down by device company size, device class (Class 2 and 3) or therapeutic area. Additionally, profiles of device manufacturers and their individual products allow for comparisons and provide guidelines for companies and products with a similar background. The report will answer these critical questions about medical device new product planning and commercialization:
These principles are signposts to help improve your medical device product commercialization in the US. These points emphasize central and critical recommendations contained within this study.
Percentage of Companies Using Specific Regulatory Pathways,
by Medical Device Product Novelty and Classification